Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Blend Labs (BLND) Cash & Equivalents (2020 - 2025)

Blend Labs has reported Cash & Equivalents over the past 6 years, most recently at $43.6 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $43.6 million for Q4 2025, up 14.74% from a year ago — trailing twelve months through Dec 2025 was $43.6 million (up 14.74% YoY), and the annual figure for FY2025 was $43.6 million, up 14.74%.
  • Cash & Equivalents for Q4 2025 was $43.6 million at Blend Labs, down from $55.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for BLND hit a ceiling of $369.7 million in Q2 2021 and a floor of $23.5 million in Q4 2023.
  • Median Cash & Equivalents over the past 5 years was $66.9 million (2024), compared with a mean of $116.9 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 4997.56% in 2021 and later crashed 81.08% in 2023.
  • Blend Labs' Cash & Equivalents stood at $213.1 million in 2021, then crashed by 41.71% to $124.2 million in 2022, then crashed by 81.08% to $23.5 million in 2023, then soared by 61.68% to $38.0 million in 2024, then increased by 14.74% to $43.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $43.6 million (Q4 2025), $55.0 million (Q3 2025), and $36.5 million (Q2 2025) per Business Quant data.